It is reported that in 2022, Shandong Kangqiao Biotechnology Co., Ltd.'s strategic product pyraclostrobin will make important progress in the development of the North American market. In August 2022, the Canadian Pest Management Regulatory Agency (PMRA) officially approved the registration of Shandong Concho pyraclostrobin 250 EC (registration number: 34601). This is another important breakthrough made by the company in the North American market after Shandong Concho pyraclostrobin technical was independently registered in Canada (registration number: 33728) in March 2020.
Pyraclostrobin is widely used in the world, and has been registered and applied on more than 180 crops in more than 80 countries. It is a high-activity, high-efficiency, low-toxicity, broad-spectrum all-purpose fungicide. Pyraclostrobin has protective and therapeutic effects, has good penetration and systemic effects, and shows good activity against almost all fungal diseases, and has the effects of plant health care, stress resistance and yield increase. In 2019, the global sales of pyraclostrobin were US$1.015 billion, making it the third largest fungicide in the world.
Since the patent protection of pyraclostrobin expired in China in 2015, Chinese companies have accelerated the deployment of this product. As the most important manufacturer of pyraclostrobin in China, Shandong Kangqiao has been focusing on the process and dosage form innovation of pyraclostrobin and other advantageous varieties. The company successfully developed the pyraclostrobin process in 2011, applied for an invention patent in 2014, and issued certificates for both the original drug and the preparation in 2015. At present, the company has a production capacity of 1,500 tons of pyraclostrobin technical, and the technology can guarantee the nano-level particle size of the suspending agent. The application crops have expanded from the initial application of fruit trees and field applications to the registration of medicinal materials, flowers and other crops.
In the future, Shandong Concho will continue to innovate on the integration of original drug preparations around important varieties such as pyraclostrobin, spirodiclofen, and thifuramide, and will continue to explore along the route of quality improvement, cost reduction, and efficiency enhancement . At the same time, self-registration of products has been carried out in more overseas markets such as the European Union and Brazil, laying a solid foundation for international development.
Source: AgroPages
